OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 9.6 USD -1.13% Market Closed
Market Cap: 97.2m USD

Wall Street
Price Targets

OPTN Price Targets Summary
OptiNose Inc

There are no price targets for OPTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
OptiNose Inc Competitors:
Price Targets
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
6% Upside
UCB
Ucb SA
11% Upside
LABB
Genomma Lab Internacional SAB de CV
57% Upside
SPL
Starpharma Holdings Ltd
46% Upside
600535
Tasly Pharmaceutical Group Co Ltd
15% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
32% Upside
300363
Porton Pharma Solutions Ltd
28% Upside
512
Grand Pharmaceutical Group Ltd
49% Upside

Revenue
Forecast

Revenue Estimate
OptiNose Inc

For the last 8 years the compound annual growth rate for OptiNose Inc's revenue is 6%. The projected CAGR for the next 3 years is 21%.

6%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OptiNose Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
OptiNose Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTN's stock price target?
Not Available

OPTN doesn't have any price targets made by Wall Street professionals.

What is OptiNose Inc's Revenue forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for OptiNose Inc's revenue is 6%. The projected CAGR for the next 3 years is 21%.

Back to Top